Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/112443
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJiménez, Amanda-
dc.contributor.authorMari, Andrea-
dc.contributor.authorCasamitjana i Abellà, Roser-
dc.contributor.authorLacy Fortuny, Antonio Ma. de-
dc.contributor.authorFerrannini, Ele-
dc.contributor.authorVidal i Cortada, Josep-
dc.date.accessioned2017-06-16T07:45:04Z-
dc.date.available2017-06-16T07:45:04Z-
dc.date.issued2014-05-21-
dc.identifier.issn0012-1797-
dc.identifier.urihttp://hdl.handle.net/2445/112443-
dc.description.abstractAlthough GLP-1 has been suggested as a major factor for the marked improvement of glucose tolerance commonly seen after sleeve gastrectomy (SG), several observations challenge this hypothesis. To better understand the role of GLP-1 in the remission of type 2 diabetes mellitus (T2DM) long term after SG in humans, we conducted two separate cross-sectional studies: 1) the GLP-1 response to a standardized mixed liquid meal (SMLM) was compared in subjects with T2DM antedating SG but with different long-term (>2 years) T2DM outcomes (remission, relapse, or lack of remission) (study 1) and 2) the effect of GLP-1 receptor blockade with exendin (9-39) on glucose tolerance was examined in subjects with T2DM antedating surgery, who had undergone SG and presented with long-term T2DM remission (study 2). In study 1, we observed a comparable GLP-1 response to the SMLM regardless of the post-SG outcome of T2DM. In study 2, the blockade of GLP-1 action resulted in impaired insulin secretion but limited deterioration of glucose tolerance. Thus, our data suggest the enhanced GLP-1 secretion observed long term after SG is neither sufficient nor critical to maintain normal glucose tolerance in subjects with T2DM antedating the surgery.-
dc.format.extent6 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherAmerican Diabetes Association-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.2337/db14-0357-
dc.relation.ispartofDiabetes, 2014, vol. 63, num. 10, p. 3372-3377-
dc.relation.urihttps://doi.org/10.2337/db14-0357-
dc.rightscc-by-nc-nd (c) American Diabetes Association, 2014-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es-
dc.subject.classificationObesitat mòrbida-
dc.subject.classificationDiabetis no-insulinodependent-
dc.subject.classificationCirurgia digestiva-
dc.subject.classificationEstudi de casos-
dc.subject.otherMorbid obesity-
dc.subject.otherNon-insulin-dependent diabetes-
dc.subject.otherGastrointestinal surgery-
dc.subject.otherCase studies-
dc.titleGLP-1 and glucose tolerance after sleeve gastrectomy in morbidly obese subjects with type 2 diabetes.-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec646688-
dc.date.updated2017-06-16T07:45:04Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)
Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
646688.pdf830.88 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons